Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Oral baricitinib is effective and safe for treating alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Changing neuroactive steroids in baby male rats affects their memory and learning differently as they grow up.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Finasteride is a medicine used to treat enlarged prostate and prostate cancer, and it works by changing how testosterone works in the body.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.